Tenofovir disoproxil fumarate and coronavirus disease 2019 outcomes in men with HIV

aCAUSALab

bDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts

cStanford Center for Population Health Sciences, Stanford University School of Medicine, Palo Alto, California

dDepartment of Biostatistics, Boston University School of Public Health, Boston, Massachusetts

eDivision of Infectious Diseases, Department of Medicine, Emory University, Atlanta

fAtlanta VA Medical Center, North Druid Hills, Georgia

gDepartment of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut

hMassachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System

iDepartment of Medicine, Division of Aging, Brigham & Women's Hospital

jDepartment of Medicine, Harvard Medical School, Boston, Massachusetts

kDepartment of Internal Medicine, Yale School of Medicine, New Haven, Connecticut

lVA Connecticut Healthcare System, US Department of Veterans Affairs, Washington, DC, USA

mFaculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK

nDepartment of Medicine, Yale School of Medicine

oDivision of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut

pDepartment of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.

Correspondence to Guilin Li, Department of Epidemiology, 677 Huntington Avenue, Boston, MA 02115, USA. e-mail: [email protected]

Received 19 April, 2022

Revised 13 June, 2022

Accepted 20 June, 2022

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (http://www.AIDSonline.com).

留言 (0)

沒有登入
gif